Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Pharmaceutical Development and Technology
|
November 14, 2013
Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD
Monika Praschberger, Carolin Cornelius, Markus Schitegg, et al.
European Journal of Clinical Investigation
|
May 12, 2010
Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor
Brigitte Sturm, Melissa Helminger, Hannes Steinkellner, et al.
Biochimie
|
April 29, 2006
Differential response of iron metabolism to oxidative stress generated by antimycin A and nitrofurantoin
Brigitte Sturm, Teresa Twaroch, Birgit Knapitsch, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine
|
October 19, 2014
Iron sucrose and ferric carboxymaltose: no correlation between physicochemical stability and biological activity
Monika Praschberger, Kathrin Haider, Carolin Cornelius, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 2, 2008
Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial
Sylvia Boesch, Brigitte Sturm, Sascha Hering, et al.
Gene
|
April 17, 2017
No changes in heme synthesis in human Friedreich´s ataxia erythroid progenitor cells
Hannes Steinkellner, Himanshu Narayan Singh, Martina U Muckenthaler, et al.
Free Radical Research
|
June 20, 2007
Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl
Hilde Laggner, Markus K Muellner, Sabine Schreier, et al.
The Journal of Biological Chemistry
|
December 24, 2004
Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity?
Brigitte Sturm, Ute Bistrich, Matthias Schranzhofer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 22, 2011
Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia
Wolfgang Nachbauer, Julia Wanschitz, Hannes Steinkellner, et al.
Cerebellum (London, England)
|
May 21, 2011
Effects of erythropoietin on frataxin levels and mitochondrial function in Friedreich ataxia--a dose-response trial
Wolfgang Nachbauer, Sascha Hering, Markus Seifert, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Pharmaceutical Development and Technology
|
November 14, 2013
Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD
Monika Praschberger, Carolin Cornelius, Markus Schitegg, et al.
European Journal of Clinical Investigation
|
May 12, 2010
Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor
Brigitte Sturm, Melissa Helminger, Hannes Steinkellner, et al.
Biochimie
|
April 29, 2006
Differential response of iron metabolism to oxidative stress generated by antimycin A and nitrofurantoin
Brigitte Sturm, Teresa Twaroch, Birgit Knapitsch, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine
|
October 19, 2014
Iron sucrose and ferric carboxymaltose: no correlation between physicochemical stability and biological activity
Monika Praschberger, Kathrin Haider, Carolin Cornelius, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 2, 2008
Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial
Sylvia Boesch, Brigitte Sturm, Sascha Hering, et al.
Gene
|
April 17, 2017
No changes in heme synthesis in human Friedreich´s ataxia erythroid progenitor cells
Hannes Steinkellner, Himanshu Narayan Singh, Martina U Muckenthaler, et al.
Free Radical Research
|
June 20, 2007
Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl
Hilde Laggner, Markus K Muellner, Sabine Schreier, et al.
The Journal of Biological Chemistry
|
December 24, 2004
Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity?
Brigitte Sturm, Ute Bistrich, Matthias Schranzhofer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 22, 2011
Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia
Wolfgang Nachbauer, Julia Wanschitz, Hannes Steinkellner, et al.
Cerebellum (London, England)
|
May 21, 2011
Effects of erythropoietin on frataxin levels and mitochondrial function in Friedreich ataxia--a dose-response trial
Wolfgang Nachbauer, Sascha Hering, Markus Seifert, et al.
Page
of 3